Dare Bioscience (DARE) Competitors $2.12 +0.02 (+0.95%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.20 +0.08 (+3.77%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DARE vs. CABA, INMB, STRO, GNTA, ARTV, FBRX, IMMX, MNOV, RPTX, and PYXSShould you be buying Dare Bioscience stock or one of its competitors? The main competitors of Dare Bioscience include Cabaletta Bio (CABA), INmune Bio (INMB), Sutro Biopharma (STRO), Genenta Science (GNTA), Artiva Biotherapeutics (ARTV), Forte Biosciences (FBRX), Immix Biopharma (IMMX), MediciNova (MNOV), Repare Therapeutics (RPTX), and Pyxis Oncology (PYXS). These companies are all part of the "pharmaceutical products" industry. Dare Bioscience vs. Its Competitors Cabaletta Bio INmune Bio Sutro Biopharma Genenta Science Artiva Biotherapeutics Forte Biosciences Immix Biopharma MediciNova Repare Therapeutics Pyxis Oncology Cabaletta Bio (NASDAQ:CABA) and Dare Bioscience (NASDAQ:DARE) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment. Does the media prefer CABA or DARE? In the previous week, Dare Bioscience had 17 more articles in the media than Cabaletta Bio. MarketBeat recorded 17 mentions for Dare Bioscience and 0 mentions for Cabaletta Bio. Dare Bioscience's average media sentiment score of 0.53 beat Cabaletta Bio's score of 0.00 indicating that Dare Bioscience is being referred to more favorably in the news media. Company Overall Sentiment Cabaletta Bio Neutral Dare Bioscience Positive Do analysts recommend CABA or DARE? Cabaletta Bio currently has a consensus price target of $14.43, indicating a potential upside of 790.65%. Dare Bioscience has a consensus price target of $12.00, indicating a potential upside of 466.04%. Given Cabaletta Bio's higher probable upside, equities analysts clearly believe Cabaletta Bio is more favorable than Dare Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cabaletta Bio 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Dare Bioscience 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, CABA or DARE? Cabaletta Bio has a beta of 2.74, indicating that its stock price is 174% more volatile than the S&P 500. Comparatively, Dare Bioscience has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Do insiders & institutionals believe in CABA or DARE? 6.7% of Dare Bioscience shares are owned by institutional investors. 11.3% of Cabaletta Bio shares are owned by company insiders. Comparatively, 4.8% of Dare Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is CABA or DARE more profitable? Dare Bioscience's return on equity of 0.00% beat Cabaletta Bio's return on equity.Company Net Margins Return on Equity Return on Assets Cabaletta BioN/A -92.11% -74.08% Dare Bioscience N/A N/A -103.70% Which has better earnings & valuation, CABA or DARE? Dare Bioscience has higher revenue and earnings than Cabaletta Bio. Dare Bioscience is trading at a lower price-to-earnings ratio than Cabaletta Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCabaletta BioN/AN/A-$115.86M-$2.71-0.60Dare Bioscience$10K2,857.76-$4.05M-$2.14-0.99 SummaryCabaletta Bio and Dare Bioscience tied by winning 7 of the 14 factors compared between the two stocks. Get Dare Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DARE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DARE vs. The Competition Export to ExcelMetricDare BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.31M$3.11B$5.76B$9.58BDividend YieldN/A2.23%4.41%4.10%P/E Ratio-0.9920.8831.1026.05Price / Sales2,857.76342.78433.22103.03Price / CashN/A43.1937.7358.48Price / Book-2.268.129.536.61Net Income-$4.05M-$54.72M$3.26B$265.56M7 Day Performance-3.64%2.63%2.10%1.97%1 Month Performance-20.30%2.78%2.81%-0.36%1 Year Performance-40.28%11.01%30.56%19.03% Dare Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAREDare Bioscience2.5683 of 5 stars$2.12+1.0%$12.00+466.0%-38.0%$28.31M$10K-0.9930Analyst RevisionCABACabaletta Bio2.1383 of 5 stars$1.33-2.2%$14.43+984.9%-72.1%$69.01MN/A-0.4950INMBINmune Bio2.0352 of 5 stars$2.40-6.3%$18.40+666.7%-62.6%$68.06M$10K-0.9710STROSutro Biopharma4.3605 of 5 stars$0.77-3.7%$6.11+691.4%-81.1%$68.02M$62.04M-0.31240Analyst DowngradeGNTAGenenta Science1.9033 of 5 stars$3.54-4.7%$25.00+607.2%-14.4%$67.87MN/A0.007Positive NewsGap DownHigh Trading VolumeARTVArtiva Biotherapeutics2.8413 of 5 stars$2.56-7.2%$17.80+595.3%-71.1%$67.42M$250K0.0081FBRXForte Biosciences2.6337 of 5 stars$10.51+3.2%$61.00+480.4%+88,725.0%$66.99MN/A-0.655News CoverageOptions VolumeIMMXImmix Biopharma3.2661 of 5 stars$2.32-2.9%$7.00+201.7%-0.9%$66.63MN/A-3.019MNOVMediciNova2.5814 of 5 stars$1.33-1.5%$7.00+426.3%+7.6%$66.21M$1M-5.7810Positive NewsRPTXRepare Therapeutics2.2727 of 5 stars$1.54+0.3%$4.50+192.2%-46.5%$65.84M$53.48M-0.60180PYXSPyxis Oncology2.3396 of 5 stars$1.04-1.9%$8.67+733.3%-63.3%$65.67M$16.15M-0.6560Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume Related Companies and Tools Related Companies Cabaletta Bio Alternatives INmune Bio Alternatives Sutro Biopharma Alternatives Genenta Science Alternatives Artiva Biotherapeutics Alternatives Forte Biosciences Alternatives Immix Biopharma Alternatives MediciNova Alternatives Repare Therapeutics Alternatives Pyxis Oncology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DARE) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access